CDC Vaccine Panel Endorses Merck’s RSV Shot for Infants: A Potential Game-Changer in Pediatric Health and Pharma Investments
Merck’s New RSV Shot: A Game-Changer for Infant Health and What It Means for Investors The recent unanimous recommendation by the revamped Advisory Committee on Immunization Practices (ACIP) to include Merck’s Enflonsia in the government’s … Read more